glp-1 obesity drug news Dozens of new drugs are coming: these are the ones to watch Market Overview: GLP-1 Agonists and
Description
Moreover, growing medical tourism across Asian countries is attracting many international players to strengthen their presence through collaborations with local players
and practical and safety considerations for the use of GLP-1 RAs
One notable example of a drug delivery partnership is that NOVO Nordisk A/S has had an ongoing agreement with Emisphere Technologies Inc
Geniposide was obtained from Wako Pure Chemical Industries, Ltd (Osaka, Japan)
